Tower Research Capital LLC (Trc) Maravai Lifesciences Holdings, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 15,298 shares of MRVI stock, worth $81,538. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,298
Previous 5,343
186.32%
Holding current value
$81,538
Previous $38,000
234.21%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MRVI
# of Institutions
234Shares Held
140MCall Options Held
223KPut Options Held
19.4K-
Gtcr LLC20.2MShares$107 Million13.05% of portfolio
-
12 West Capital Management LP New York, NY14MShares$74.7 Million12.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$63.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$51.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$44.5 Million1.97% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $701M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...